Stability of Fentanyl Citrate, Hydromorphone Hydrochloride, Ketamine Hydrochloride, Midazolam, Morphine Sulfate, and Pentobarbital Sodium in Polypropylene Syringes

Purpose: Determine the stability of fentanyl 10 mcg/mL in 0.9% sodium chloride, fentanyl 10 mcg/mL in 5% dextrose, fentanyl 50 mcg/mL, hydromorphone 100 mcg/mL in 0.9% sodium chloride, ketamine 10 mg/mL, midazolam 0.4 mg/mL in 5% dextrose, midazolam 5 mg/mL, morphine 1 mg/mL in 0.9% sodium chloride,...

Full description

Saved in:
Bibliographic Details
Main Authors: Collin Anderson (Author), Mark MacKay (Author)
Format: Book
Published: MDPI AG, 2015-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d35d228aaec34809bf4a941f5f3d3cfe
042 |a dc 
100 1 0 |a Collin Anderson  |e author 
700 1 0 |a Mark MacKay  |e author 
245 0 0 |a Stability of Fentanyl Citrate, Hydromorphone Hydrochloride, Ketamine Hydrochloride, Midazolam, Morphine Sulfate, and Pentobarbital Sodium in Polypropylene Syringes 
260 |b MDPI AG,   |c 2015-12-01T00:00:00Z. 
500 |a 2226-4787 
500 |a 10.3390/pharmacy3040379 
520 |a Purpose: Determine the stability of fentanyl 10 mcg/mL in 0.9% sodium chloride, fentanyl 10 mcg/mL in 5% dextrose, fentanyl 50 mcg/mL, hydromorphone 100 mcg/mL in 0.9% sodium chloride, ketamine 10 mg/mL, midazolam 0.4 mg/mL in 5% dextrose, midazolam 5 mg/mL, morphine 1 mg/mL in 0.9% sodium chloride, morphine 1 mg/mL in 5% dextrose, and pentobarbital 50 mg/mL when stored as single drug entities at room temperature in polypropylene syringes. Methods: Four 5 mL samples of each drug and concentration were prepared in 10 mL polypropylene syringes. The samples were stored at ambient room temperature in a locked cabinet. Triplicate determinations of drug concentration for each sample were performed initially, on day 50 or 51, and on day 100 using high-performance liquid chromatography with diode-array detection. Results: With the exception of the hydromorphone 100 mcg/mL dilution, all compounds were found to contain greater than 95% of their initial concentration remaining at 100 days. Each sample remained clear and colorless when visually inspected. 
546 |a EN 
690 |a stability 
690 |a pharmacy 
690 |a fentanyl 
690 |a hydromorphone 
690 |a ketamine 
690 |a midazolam 
690 |a morphine 
690 |a pentobarbital 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmacy, Vol 3, Iss 4, Pp 379-385 (2015) 
787 0 |n http://www.mdpi.com/2226-4787/3/4/379 
787 0 |n https://doaj.org/toc/2226-4787 
856 4 1 |u https://doaj.org/article/d35d228aaec34809bf4a941f5f3d3cfe  |z Connect to this object online.